US 11905313
Recombinant RSV G proteins and their use
granted A61KA61K2039/525A61K2039/5258
Quick answer
US patent 11905313 (Recombinant RSV G proteins and their use) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Feb 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Feb 20 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 28
- CPC classes
- A61K, A61K2039/525, A61K2039/5258, A61K2039/53, A61K2039/575